Synthesis and opioid binding activity of dermorphin analogues containing cyclic beta-amino acids. 1997

B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
Biological Research Center, Hungarian Academy of Sciences, Szeged.

In the present work, eight conformationally constrained analogues of the mu specific opioid peptide dermorphin were synthesized by replacing D-Ala2 with stereoisomers of beta-amino-cycloalkane or cycloalkene carboxylic acids. The resulting peptides were tested for their potency to mu and delta opioid binding sites of rat brain membranes labelled with [3H]Tyr1-D-Ala2-MePhe4-Gly-ol, [3H]DAMGO and [3H]Ile5,6deltorphin, respectively. All of the new derivatives displayed highly attenuated binding to both receptor types, albeit the decrease in their potency seemed to be less in the case of delta binding. Trans position of the beta-amino groups resulted in higher binding affinities than that of the corresponding cis isomers, the latter being more flexible than the former. It is concluded that conformational constraints caused either by a rigid ring structure or cis isomers instead of D-Ala2 in dermorphin-derived peptides are unfavourable for binding activity to either opioid receptors. We propose that interaction of the larger heptapeptide derivatives of dermorphins with the mu receptor is distinct from that of the tetrapeptide morphiceptin.

UI MeSH Term Description Entries
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003509 Cyclohexanecarboxylic Acids Carboxylic acid derivatives of cyclohexane. Acids, Cyclohexanecarboxylic
D000598 Amino Acids, Cyclic A class of amino acids characterized by a closed ring structure. Cyclic Amino Acids,Acids, Cyclic Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer

Related Publications

B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
December 2000, Bioorganic & medicinal chemistry letters,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
November 2009, Journal of peptide science : an official publication of the European Peptide Society,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
October 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
August 2007, Journal of peptide science : an official publication of the European Peptide Society,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
December 1987, Il Farmaco; edizione scientifica,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
January 1990, Biopolymers,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
June 2005, Journal of peptide science : an official publication of the European Peptide Society,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
February 1995, Arzneimittel-Forschung,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
October 1995, Biopolymers,
B Bozü, and F Fülöp, and G K Tóth, and G Tóth, and M Szücs
May 2013, European journal of medicinal chemistry,
Copied contents to your clipboard!